Mark Tarr said three hospitals totaling 139 beds opened in the first half; five more are expected before year-end.
Full-year 2026 guidance was raised, with net operating revenue seen at USD 6.41 billion to USD 6.49 billion; board lifted share repurchase authorization to USD 1 billion.
Q2 results and operating trends
Encompass Health Q2 2026 net operating revenue rose 9.6% to USD 1.6 billion; income from continuing operations per diluted share increased 10.7% to USD 1.55.
Adjusted EBITDA climbed 9.2% to USD 348 million; cash flows from operating activities increased 4.6% to USD 282.6 million.
Discharges grew 5.6% to 68,895; net patient revenue per discharge increased 3.9% to USD 22,521.